SUBCUTANEOUS FAT
Clinical trials for SUBCUTANEOUS FAT explained in plain language.
Never miss a new study
Get alerted when new SUBCUTANEOUS FAT trials appear
Sign up with your email to follow new studies for SUBCUTANEOUS FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Belly fat be gone? new injection heads to phase 3 trial
Symptom relief Not yet recruitingThis study tests an injection called CBL-514 to see if it can safely reduce belly fat. About 320 adults with moderate to severe abdominal fat will receive either the drug or a placebo. The goal is to measure fat reduction using MRI and patient reports.
Matched conditions: SUBCUTANEOUS FAT
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
Belly fat melting shot? phase 3 trial launches
Symptom relief Not yet recruitingThis study tests an injection called CBL-514 to see if it can safely reduce belly fat. About 300 adults with moderate to severe abdominal fat will receive either the drug or a placebo. The goal is to measure fat loss with MRI and patient reports.
Matched conditions: SUBCUTANEOUS FAT
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Apr 26, 2026 19:36 UTC